申请人:AbbVie Ireland Unlimited Company
公开号:EP3438106A1
公开(公告)日:2019-02-06
This invention relates to processes and intermediates for making compounds which are effective in inhibiting replication of Hepatitis C virus (HCV).
本发明涉及用于制造有效抑制丙型肝炎病毒(HCV)复制的化合物的工艺和中间体。